Expression of Cxcr3 and Its ligands, IP-10 and I-TAC, In Hepatitis, Cirrhosis and Hepatocellular Carcinoma

Lin, C. K., Jin, J. S., Yu, C. P., & Tsai, W. C. (2011). Expression of LGR8 and Related Biomarkers in Hepatocellular Carcinoma: Correlation with Clinicopathological Parameters. The Chinese Journal of Physiology, 54(3), 161-168. https://doi.org/10.4077/CJP.2011.AMM021
吳俊杰（2010）。The Role of CD66a Revealed by Its Expression Pattern in Hepatocellular Carcinoma〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0011-2808201010593900
Dong, Z. Z., Yao, D. F., Wang, Y. L., Shen, J. J., Zhang, C. G., Huang, H., Qiu, L. W., Wu, W., & Wu, X. H. (2008). Abnormal Expression of Hepatic Transforming Growth Factor-β1 at the Early Stage of Hepatocellular Carcinoma Formation. Journal of Cancer Molecules, 4(3), 91-96. https://doi.org/10.29685/JCM.200808.0003
Chan, H. M. (2012). Overexpression of translationally controlled tumor protein (TCTP) predisposes to hepatocellular carcinoma [doctoral dissertation, The University of Hong Kong]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0029-0511201300008999
Liu, C. C. (2016). The Roles of 14-3-3σ in Regulating Cell Migration and Invasion of Hepatocellular Carcinoma [doctoral dissertation, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU201602675